Search Top Featured Websites...
Breaking Top Featured Content:

Less prostate cancer screening reduces overdiagnosis but may miss aggressive cases

Over the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to reduce the overdiagnosis and overtreatment of men with low-grade prostate cancer. Now, researchers have found that while these efforts have been effective, the incidence of higher-grade disease and metastasis at diagnosis have risen.

Continue Reading at ScienceDaily.com Click Here.

Press Release Distribution Service
Share your business, services, products, events & news. Get added to TopFeatured.com. DETAILS.